|
Code
|
9803E
|
|
MA number
|
59/0847/96-S
|
|
Product Form:
|
sus inj 25x0,5 ml/720 E.U. (liek.inj.skl.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
GlaxoSmithKline Biologicals S.A., Belgium
|
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J07 |
VACCINES |
| J07B |
VIRAL VACCINES |
| J07BC |
Hepatitis vaccines |
| J07BC02 |
Hepatitis A, inactivated, whole virus |
|
|
Shelf life:
|
36 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intramuscular use
|
PIL_Havrix Junior 720 sus inj_05.2025.pdf
